CSPC Pharmaceutical Group Limited (CSPCY)
USD 2.94
(13.08%)
USD 2.94
(13.08%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.49 CNY | -2.94% |
| 2022 | 2.04 CNY | 8.51% |
| 2021 | 1.88 CNY | 8.67% |
| 2020 | 1.73 CNY | 39.52% |
| 2019 | 1.24 CNY | 0.0% |
| 2018 | - HKD | -100.0% |
| 2017 | 0.79 HKD | 19.7% |
| 2016 | 0.66 HKD | 34.69% |
| 2015 | 0.49 HKD | 36.11% |
| 2014 | 0.36 HKD | 28.57% |
| 2013 | 0.28 HKD | -88.71% |
| 2012 | 2.48 HKD | 651.52% |
| 2011 | 0.33 HKD | -62.07% |
| 2010 | 0.87 HKD | -25.0% |
| 2009 | 1.16 HKD | 3.57% |
| 2008 | 1.12 HKD | 86.67% |
| 2007 | 0.60 HKD | 2770.81% |
| 2006 | 0.02 HKD | -90.5% |
| 2005 | 0.22 HKD | -37.14% |
| 2004 | 0.35 HKD | -52.7% |
| 2003 | 0.74 HKD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.14 CNY | 7.69% |
| 2024 Q2 | 0.12 CNY | 0.0% |
| 2023 Q4 | 0.13 CNY | -7.14% |
| 2023 Q2 | 0.14 CNY | -70.83% |
| 2023 Q1 | 0.48 CNY | 220.0% |
| 2023 FY | - CNY | -2.94% |
| 2023 Q3 | 0.14 CNY | 0.0% |
| 2022 Q3 | 0.14 CNY | -6.67% |
| 2022 FY | - CNY | 8.51% |
| 2022 Q1 | 0.47 CNY | 261.54% |
| 2022 Q2 | 0.15 CNY | -68.09% |
| 2022 Q4 | 0.15 CNY | 7.14% |
| 2021 Q4 | 0.13 CNY | 0.0% |
| 2021 FY | - CNY | 8.67% |
| 2021 Q3 | 0.13 CNY | -18.75% |
| 2021 Q1 | 0.15 CNY | -6.25% |
| 2021 Q2 | 0.16 CNY | 6.67% |
| 2020 Q1 | 0.11 CNY | 30.18% |
| 2020 Q4 | 0.16 CNY | 45.45% |
| 2020 FY | - CNY | 39.52% |
| 2020 Q3 | 0.11 CNY | 0.0% |
| 2020 Q2 | 0.11 CNY | 0.0% |
| 2019 Q1 | 0.09 CNY | 20.31% |
| 2019 Q3 | 0.09 CNY | -2.5% |
| 2019 Q4 | 0.08 CNY | -1.52% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q2 | 0.09 CNY | -5.38% |
| 2018 Q1 | 0.08 CNY | 26.39% |
| 2018 Q2 | 0.08 CNY | -1.82% |
| 2018 Q3 | 0.07 CNY | -4.23% |
| 2018 Q4 | 0.08 CNY | 6.62% |
| 2018 FY | - HKD | -100.0% |
| 2017 FY | - HKD | 19.7% |
| 2017 Q4 | 0.06 CNY | -2.87% |
| 2017 Q3 | 0.06 CNY | 8.09% |
| 2017 Q2 | 0.06 CNY | 5.83% |
| 2017 Q1 | 0.05 CNY | 19.87% |
| 2016 Q3 | 0.05 CNY | 0.87% |
| 2016 Q4 | 0.05 CNY | -1.29% |
| 2016 Q2 | 0.05 CNY | 4.31% |
| 2016 FY | - HKD | 34.69% |
| 2016 Q1 | 0.04 CNY | 18.55% |
| 2015 Q4 | 0.04 CNY | 1.36% |
| 2015 FY | - HKD | 36.11% |
| 2015 Q3 | 0.04 CNY | -0.27% |
| 2015 Q2 | 0.04 CNY | 5.44% |
| 2015 Q1 | 0.03 CNY | 14.8% |
| 2014 Q4 | 0.03 CNY | 8.96% |
| 2014 FY | - HKD | 28.57% |
| 2014 Q1 | 0.02 CNY | 21.28% |
| 2014 Q2 | 0.03 CNY | 29.82% |
| 2014 Q3 | 0.03 CNY | -5.74% |
| 2013 Q4 | 0.02 CNY | -12.15% |
| 2013 FY | - HKD | -88.71% |
| 2013 Q3 | 0.02 CNY | 15.68% |
| 2013 Q2 | 0.02 CNY | -5.13% |
| 2013 Q1 | 0.02 CNY | 0.0% |
| 2012 FY | - HKD | 651.52% |
| 2011 FY | - HKD | -62.07% |
| 2010 FY | - HKD | -25.0% |
| 2009 FY | - HKD | 3.57% |
| 2008 FY | - HKD | 86.67% |
| 2007 FY | - HKD | 2770.81% |
| 2006 FY | - HKD | -90.5% |
| 2005 FY | - HKD | -37.14% |
| 2004 FY | - HKD | -52.7% |
| 2003 FY | - HKD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AstraZeneca PLC | 3.84 USD | 87.24% |
| Bristol-Myers Squibb Company PFD CONV 2 | 3.88 USD | 87.371% |
| CSPC Pharmaceutical Group Limited | 0.07 USD | -600.0% |
| Clarus Therapeutics Holdings, Inc. | -8.04 USD | 106.095% |
| Novartis AG | 7.63 USD | 93.578% |
| PT Kalbe Farma Tbk. | 0.00 USD | -12464.103% |